Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Red-light therapy may outperform ortho-k lenses in slowing childhood myopia progression, study finds
  • Myopia

Red-light therapy may outperform ortho-k lenses in slowing childhood myopia progression, study finds

Kelsey Moroz

Repeated low-level red-light (RLRL) therapy may be slightly more effective than orthokeratology (ortho-k) lenses in slowing myopia progression in children, as indicated by reduced axial length growth over a 2-year period, according to a study.

A recent study has compared the effectiveness of RLRL therapy and ortho-k lenses in controlling myopia progression among children aged 6 to 14. The study enrolled 138 children: 67 received RLRL therapy, and 71 used ortho-k lenses. Both groups had initial myopia of ≤-0.50 D and astigmatism ≤2.50 D, with follow-up data collected over 2 years.

Children undergoing RLRL therapy had significantly less axial length growth than those using ortho-k lenses. After 1 year, axial length growth in the RLRL group was 0.03 mm on average, compared to 0.28 mm in the ortho-k group. Although the difference between the 2 groups narrowed in the second year, RLRL therapy still maintained a lower overall axial length growth rate (0.10 mm per year) than ortho-k lenses (0.25 mm per year).

Reference
Sun JR, Du ZQ, Wu GY. Efficacy comparison of repeated low-level red-light therapy and orthokeratology lenses for myopia control. Optom Vis Sci. 2024;doi: 10.1097/OPX.0000000000002197. Epub ahead of print. PMID: 39485347.

Share

Related Content

  • Myopia

Long-term DIMS lens users report high satisfaction despite cost barrier

  • Myopia

Low-dose atropine slowed myopia progression in children with advanced myopia in pilot trial

  • Myopia

Red-light therapy outperforms low-dose atropine in altering macular morphology

  • Myopia

Axial length monitoring may help assess myopia control success in clinical practice

  • Myopia

Switching myopia-control spectacles may temporarily slow progression in some children

  • Contact Lenses

Extended-wear rigid gas-permeable lenses show long-term viability in pediatric aphakia

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon